BPC-157, the recovery peptide with a very small human record

Strong animal data, enthusiastic anecdotes, and almost no human trials.

What it is

BPC-157 is a synthetic fragment of a protein found in human gastric juice. Its reputation comes from rodent studies on tendon, ligament, muscle, and gut lining repair.

How it works

The most cited mechanism is angiogenesis, the growth of new blood vessels into damaged tissue. More blood supply to a tendon or a stretch of gut means more of what repair needs arriving where it is needed. It also appears to influence growth hormone receptor expression in tendon cells, which is one explanation offered for the tendon results.

What people notice

Reports cluster around joint and tendon discomfort easing over two to six weeks, and around gut symptoms settling. This is anecdote at scale, not trial evidence, and it should be read that way.

What to watch for

The honest caveat is the evidence base. Human trials are scarce, long-term safety data does not exist, and angiogenesis is a mechanism worth thinking carefully about for anyone with a cancer history. Product quality varies widely between sources, which matters more here than for compounds with pharmaceutical supply.

One thing to remember

Give any recovery protocol a fixed end date before you start it, so you can tell whether it did anything.